SEIDEL, Laurence ; Centre Hospitalier Universitaire de Liège - CHU > Département de gestion des systèmes d'informations (GSI) > Secteur d'appui à la recherche clinique et biostatistique
Michiels, Johan
Willems, Betty
Goossens, Maria E.
Beguin, Yves ; Université de Liège - ULiège > Département des sciences cliniques > Hématologie
Ariën, K.K., Heyndrickx, L., Michiels, J., Vereecken, K., Van Lent, K., Coppens, S., Pannus, P., Martens, G.A., Van Esbroeck, M., Goossens, M.E., et al. Three doses of the BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 B.1.1.529 (Omicron) variant of concern. Preprint at MedRxiv, 2021 2021.12.23.21268316.
Canti, L., Humblet-Baron, S., Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., Servais, S., Willems, E., Ehx, G., et al. Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. J. Hematol. Oncol., 14, 2021, 174.
Gruell, H., Vanshylla, K., Tober-Lau, P., Hillus, D., Schommers, P., Lehmann, C., Kurth, F., Sander, L.E., Klein, F., mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nat. Med., 2022, 10.1038/s41591-021-01676-0.
Jurdi, A.A., Gassen, R.B., Borges, T.J., Lape, I.T., Morena, L., Efe, O., Solhjou, Z., Fekih, R.E., Deban, C., Bohan, B., et al. Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients. MedRxiv, 2022 Preprint at 2022.01.03.22268649.
Le Bourgeois, A., Coste-Burel, M., Guillaume, T., Peterlin, P., Garnier, A., Imbert, B.-M., Drumel, T., Mahé, B., Dubruille, V., Blin, N., et al. Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant. Br. J. Haematol., 2021, 10.1111/bjh.17911.
Levin, E.G., Lustig, Y., Cohen, C., Fluss, R., Indenbaum, V., Amit, S., Doolman, R., Asraf, K., Mendelson, E., Ziv, A., et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. N. Engl. J. Med., 385, 2021, e84.
Maillard, A., Redjoul, R., Klemencie, M., Labussiere-Wallet, H., Le Bourgeois, A., D'Aveni, M., Huynh, A., Berceanu, A., Marchand, T., Chantepie, S.P., et al. Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients. Blood 139 (2022), 134–137, 10.1182/blood.2021014232.
Redjoul, R., Le Bouter, A., Beckerich, F., Fourati, S., Maury, S., Antibody response after second BNT162b2 dose in allogeneic HSCT recipients. Lancet 398 (2021), 298–299.
Redjoul, R., Le Bouter, A., Parinet, V., Fourati, S., Maury, S., Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT. Lancet Haematol. 8 (2021), e681–e683.
Zeng, C., Evans, J.P., Chakravarthy, K., Qu, P., Reisinger, S., Song, N.-J., Rubinstein, M.P., Shields, P.G., Li, Z., Liu, S.-L., COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer. Cancer Cell, 40, 2021, 10.1016/j.ccell.2021.12.014.
